How do patients participate?

Patients recently diagnosed with myeloma, plasma cell leukaemia, plasmacytoma or MGUS will be identified by their clinician. Your clinician or a member of their staff will provide you with information and a MRDR brochure. They will then will ask you to participate before your details are entered into the registry.

You can request for their details to be removed from the registry at any time, even after your details have been entered, without any consequences for your treatment or care.